For the Inventor, By the Inventor

Enter assignee name

Phoenix, AZ, United States of America

Gtx Corporation

USPTO Granted Patents = 55

CIPO Patents = 28

EPO Patents = 6

Trademarks = 5

Forward Citations = 904

Loading Chart...

Loading Chart...

93 inventors (with patents filed for the assignee):

James T Dalton (33 out of 101 patents)

Ramesh Narayanan (18 out of 42 patents)

Duane Douglas Miller (18 out of 119 patents)

4. Mitchell S Steiner (12 out of 37 patents)

5. Sunjoo Ahn (10 out of 20 patents)

6. Patrick E Bertagna (9 out of 29 patents)

7. Charles B Duke (9 out of 13 patents)

8. Christopher C Coss (8 out of 12 patents)

9. Thamarai Ponnusamy (7 out of 28 patents)

10. Dong-Jin Hwang (7 out of 23 patents)

11. Yali He (7 out of 32 patents)

12. Seoung-Soo Hong (6 out of 10 patents)

13. Wei Li (6 out of 15 patents)

14. Andrew Hamish Duncan (4 out of 7 patents)

15. Li Wang (4 out of 7 patents)

Core Competencies:

Tracking Device

Selective Androgen Receptor Degrader

Selective Androgen Receptor Modulators

Cancer Treatment

Footwear Technology

Nuclear Receptor Binding Agents

Estrogen Receptor Ligands

GPS Footwear

Meibomian Gland Dysfunction

Prodrugs

Image Processing

Shape Recognition

55 patents: Sort by Forward Citations

1. 11272761 - System and method for embedding a tracking device in a footwear insole (2022-03-15),

2. 10743615 - System and method for embedding a tracking device in a footwear insole (2020-08-18),

3. 10441570 - Selective androgen receptor degrader (SARD) Ligands and methods of use thereof (2019-10-15),

4. 10314807 - Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) (2019-06-11),

5. 10301285 - Compounds for treatment of cancer (2019-05-28),

6. 10292453 - System and method for embedding a tracking device in a footwear insole (2019-05-21),

7. 10258596 - Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) (2019-04-16),

8. 10155728 - Compounds for treatment of cancer (2018-12-18),

9. 10093613 - Selective androgen receptor degrader (SARD) ligands and methods of use thereof (2018-10-09),

10. 10035763 - Selective androgen receptor degrader (SARD) ligands and methods of use thereof (2018-07-31),

11. 10017471 - Selective androgen receptor degrader (SARD) ligands and methods of use thereof (2018-07-10),

12. 9981915 - Compounds for treatment of cancer (2018-05-29),

13. 9969683 - Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS) (2018-05-15),

14. 9910862 - System and method for processing location data (2018-03-06),

15. 9854872 - System and method for embedding a tracking device in a footwear insole (2018-01-02),

GTX Corporation is a global technology company specializing in innovative software solutions. With over 20 years of industry experience, we provide comprehensive services in software development, artificial intelligence, and data analytics. Our team of experts leverages cutting-edge technologies to help businesses transform digitally and achieve their goals. Visit our website to learn more about our offerings and how we can assist your organization in driving success.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

55 Patents

#20 in Phoenix, AZ

#80 in Arizona

#6,231 in US

#12,527 in the World

Phoenix, AZ, United States of America

Gtx Corporation

Forward Citations = 904

93 inventors:

James T Dalton (33 out of 101 patents)

Ramesh Narayanan (18 out of 42 patents)

Duane Douglas Miller (18 out of 119 patents)

4. Mitchell S Steiner (12 out of 37 patents)

5. Sunjoo Ahn (10 out of 20 patents)

Please report any incorrect information to support@idiyas.com

Loading…